Publications by authors named "Andrew Taggart"

Claim this Profile
E
Emerging antiarrhythmic drug therapy for atrial fibrillation.
Steven A Lubitz, Andrew K P Taggart, Claudio Gimpelewicz, Christopher J O'Donnell

Heart Rhythm O2· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a brain-sparing GIRK1/4 inhibitor for pharmacological cardioversion of atrial fibrillation.
Stefan Peukert, Hatice Belgin Gulgeze Efthymiou, Ruowei Mo, Yunshan Peng, Fupeng Ma, Andrew K P Taggart

Bioorg Med Chem Lett· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of authentic atrial fibrillation in commonly used murine atrial fibrillation models.
Fumin Fu, Michael Pietropaolo, Lei Cui, Shilpa Pandit, Weiyan Li, Andrew K P Taggart

PLoS One· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of DGAT2 Inhibitors Using Mass Spectrometry.
Xuelei S Song, Jiaping Zhang, Xun Chen, Oksana Palyha, Christine Chung, Andrew Taggart

J Biomol Screen· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Pharmacology of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors.
Jason E Imbriglio, Dong-Ming Shen, Rui Liang, Ken Marby, Ming You, Andrew Taggart

J Med Chem· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design and implementation of a generic lipopeptide scanning platform to enable the identification of 'locally acting' agonists for the apelin receptor.
Stephen C McKeown, Frederic J Zecri, Eric Fortier, Andrew Taggart, Lilya Sviridenko

Bioorg Med Chem Lett· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.
Brett Lauring, Andrew K P Taggart, James R Tata, Richard Dunbar, Luzelena Caro

Sci Transl Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans.
P Douglas Boatman, Brett Lauring, Thomas O Schrader, Michelle Kasem, Benjamin R Johnson, Andrew K Taggart

J Med Chem· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species.
David G McLaren, Timothy He, Sheng-Ping Wang, Vivienne Mendoza, Raymond Rosa, Andrew Taggart

J Lipid Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME properties.
Jason E Imbriglio, Daniel DiRocco, Rena Bodner, Subharekha Raghavan, Weichun Chen, Andrew K P Taggart

Bioorg Med Chem Lett· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a.
Jason E Imbriglio, Sookhee Chang, Rui Liang, Subharekha Raghavan, Darby Schmidt, Andrew K P Taggart

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib.
Laurent Yvan-Charvet, Jelena Kling, Tamara Pagler, Hongna Li, Brian Hubbard, Andrew K Taggart

Arterioscler Thromb Vasc Biol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthranilic acid replacements in a niacin receptor agonist.
Darby Schmidt, Abigail Smenton, Subharekha Raghavan, Hong Shen, Fa-Xiang Ding, Andrew Taggart

Bioorg Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A.
Fa-Xiang Ding, Hong C Shen, Larrisa C Wilsie, Mihajlo L Krsmanovic, Andrew K Taggart

Bioorg Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).
P Douglas Boatman, Thomas O Schrader, Michelle Kasem, Benjamin R Johnson, Philip J Skinner, Andrew K Taggart

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate.
Hong C Shen, Fa-Xiang Ding, Subharekha Raghavan, Qiaolin Deng, Silvi Luell, Andrew K Taggart

J Med Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia.
Darby Schmidt, Abigail Smenton, Subharekha Raghavan, Ester Carballo-Jane, Silvi Lubell, Andrew Taggart

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenolic acids suppress adipocyte lipolysis via activation of the nicotinic acid receptor GPR109A (HM74a/PUMA-G).
Ning Ren, Rebecca Kaplan, Melba Hernandez, Kang Cheng, Lan Jin, Andrew K P Taggart

J Lipid Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.
Jason E Imbriglio, Sookhee Chang, Rui Liang, Subharekha Raghavan, Darby Schmidt, Andrew K P Taggart

Bioorg Med Chem Lett· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats.
Hong C Shen, Fa-Xiang Ding, Qiaolin Deng, Larissa C Wilsie, Mihajlo L Krsmanovic, Andrew K Taggart

J Med Chem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of GPR81 in lactate-mediated reduction of adipose lipolysis.
Tian-Quan Cai, Ning Ren, Lan Jin, Kang Cheng, Shera Kash, Andrew K P Taggart

Biochem Biophys Res Commun· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A.
Hong C Shen, Andrew K P Taggart, Larissa C Wilsie, M Gerard Waters, Milton L Hammond

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular modeling aided design of nicotinic acid receptor GPR109A agonists.
Qiaolin Deng, Jessica L Frie, Daria M Marley, Richard T Beresis, Ning Ren, Andrew K P Taggart

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice.
Graeme Semple, Philip J Skinner, Tawfik Gharbaoui, Young-Jun Shin, Jae-Kyu Jung, Andrew K Taggart

J Med Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrahydro anthranilic acid as a surrogate for anthranilic acid: application to the discovery of potent niacin receptor agonists.
Subharekha Raghavan, G Scott Tria, Hong C Shen, Fa-Xiang Ding, Andrew K Taggart

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis